BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Beckman Coulter, Inc. (BEC) Announces Sale Of Minority Interest In Agencourt Personal Genomics For About $50 Million In Cash


5/30/2006 10:33:09 AM

FULLERTON, Calif., May 30 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. announced today it has entered into an agreement to sell the company's minority interest in Agencourt Personal Genomics (APG), a developer of next generation genetic analysis technologies. This follows from an agreement between APG and Applied Biosystems Group, an Applera Corporation business, announced earlier today, whereby Applied Biosystems will acquire APG subject to regulatory and other customary closing conditions. Beckman Coulter acquired shares of APG in conjunction with its acquisition of Agencourt Bioscience in May 2005. Beckman Coulter expects to receive about $50 million in cash from the transaction which is anticipated to close in the third quarter of 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum -- from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing -- Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, California, reported 2005 annual sales of $2.44 billion with 71.5 percent of this amount generated by recurring revenue from supplies, test kits, services and operating-type lease payments. For more information, visit www.beckmancoulter.com.

Contact: Robert Raynor

(714) 773-7620 Director, Investor Relations

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comBeckman Coulter, Inc.

CONTACT: Robert Raynor, Director, Investor Relations of Beckman Coulter,Inc., +1-714-773-7620



Read at BioSpace.com
Read at Reuters

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->